scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1092337803 |
P356 | DOI | 10.1038/ONC.2017.393 |
P932 | PMC publication ID | 6545484 |
P698 | PubMed publication ID | 29059173 |
P2093 | author name string | Y Qin | |
X Fan | |||
H Zhou | |||
J Fu | |||
X Yu | |||
L Song | |||
Z Zhuang | |||
J Ling | |||
S Ji | |||
P J Chiao | |||
P2860 | cites work | SLUG is required for SOX9 stabilization and functions to promote cancer stem cells and metastasis in human lung carcinoma | Q23920671 |
Genetics and biology of pancreatic ductal adenocarcinoma | Q26765438 | ||
The Mcm2-7 replicative helicase: a promising chemotherapeutic target | Q26861045 | ||
Initiating DNA synthesis: from recruiting to activating the MCM complex | Q28209642 | ||
Deciphering the mechanisms of tumorigenesis in human pancreatic ductal epithelial cells | Q30536268 | ||
Beta-catenin blocks Kras-dependent reprogramming of acini into pancreatic cancer precursor lesions in mice | Q33604913 | ||
Secreted interleukin-1alpha induces a metastatic phenotype in pancreatic cancer by sustaining a constitutive activation of nuclear factor-kappaB | Q33799457 | ||
Oncogenic activation of NF-kappaB. | Q33849388 | ||
Cooperativity of oncogenic K-ras and downregulated p16/INK4A in human pancreatic tumorigenesis | Q33910221 | ||
Modulation of pancreatic cancer chemoresistance by inhibition of TAK1 | Q35143975 | ||
MDC1 functionally identified as an androgen receptor co-activator participates in suppression of prostate cancer. | Q35656832 | ||
Eukaryotic MCM proteins: beyond replication initiation | Q35684975 | ||
MDC1 Enhances Estrogen Receptor-mediated Transactivation and Contributes to Breast Cancer Suppression | Q35891320 | ||
KrasG12D-induced IKK2/β/NF-κB activation by IL-1α and p62 feedforward loops is required for development of pancreatic ductal adenocarcinoma. | Q35990138 | ||
NF-kB in development and progression of human cancer | Q36108761 | ||
SOX9, a potential tumor suppressor in cervical cancer, transactivates p21WAF1/CIP1 and suppresses cervical tumor growth | Q36299791 | ||
Oncogenic Kras maintains pancreatic tumors through regulation of anabolic glucose metabolism | Q36319414 | ||
Signaling networks controlled by the MRN complex and MDC1 during early DNA damage responses | Q36476150 | ||
Upregulation of sex-determining region Y-box 9 (SOX9) promotes cell proliferation and tumorigenicity in esophageal squamous cell carcinoma | Q36544540 | ||
NF-kappa B as a target for cancer therapy | Q36709532 | ||
MDC1 regulates intra-S-phase checkpoint by targeting NBS1 to DNA double-strand breaks | Q36837486 | ||
Epigenetic regulation of SOX9 by the NF-κB signaling pathway in pancreatic cancer stem cells | Q37179115 | ||
The cellular response to DNA damage: a focus on MDC1 and its interacting proteins | Q37843633 | ||
Roles for KRAS in pancreatic tumor development and progression | Q38102106 | ||
Sox9 and programming of liver and pancreatic progenitors | Q38103364 | ||
The role of SOX9 transcription factor in pancreatic and duodenal development | Q38117400 | ||
Transcriptional up-regulation of Sox9 by NF-κB in endometrial carcinoma cells, modulating cell proliferation through alteration in the p14(ARF)/p53/p21(WAF1) pathway | Q39331266 | ||
Bone morphogenetic protein 4 (BMP4) is required for migration and invasion of breast cancer | Q39428841 | ||
Notch 2-positive progenitors with the intrinsic ability to give rise to pancreatic ductal cells | Q40415546 | ||
Inhibition of constitutive NF-kappa B activity by I kappa B alpha M suppresses tumorigenesis | Q40666413 | ||
Growth and metastasis of lung adenocarcinoma is potentiated by BMP4-mediated immunosuppression | Q41689907 | ||
Identification of Sox9-dependent acinar-to-ductal reprogramming as the principal mechanism for initiation of pancreatic ductal adenocarcinoma | Q41856856 | ||
Prognostic value of interleukin 2 and interleukin 15 in peritumoral hepatic tissues for patients with hepatitis B-related hepatocellular carcinoma after curative resection | Q44476147 | ||
Clinical implication of Sox9 and activated Akt expression in pancreatic ductal adenocarcinoma | Q44907312 | ||
GSEA-P: a desktop application for Gene Set Enrichment Analysis. | Q51909999 | ||
Novel SOX9 expression during human pancreas development correlates to abnormalities in Campomelic dysplasia. | Q52117028 | ||
SOX9 expression predicts relapse of stage II colon cancer patients. | Q53147256 | ||
SOX9 regulates ERBB signalling in pancreatic cancer development. | Q53229089 | ||
The nuclear factor-kappa B RelA transcription factor is constitutively activated in human pancreatic adenocarcinoma cells | Q77904111 | ||
P433 | issue | 7 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 912-923 | |
P577 | publication date | 2017-10-23 | |
P1433 | published in | Oncogene | Q1568657 |
P1476 | title | SOX9 activity is induced by oncogenic Kras to affect MDC1 and MCMs expression in pancreatic cancer | |
P478 | volume | 37 |
Q64259744 | Exopolysaccharide, Isolated From a Novel Strain lw01 Possess an Anticancer Effect on Head and Neck Cancer - Genetic and Biochemical Evidences |
Q58697838 | Fibroblast Growth Factor 10 in Pancreas Development and Pancreatic Cancer |
Q92773787 | Immune-related somatic mutation genes are enriched in PDACs with diabetes |
Q92383002 | In silico identification of EP400 and TIA1 as critical transcription factors involved in human hepatocellular carcinoma relapse |
Q90375389 | LOTUS: A single- and multitask machine learning algorithm for the prediction of cancer driver genes |
Q98906859 | MYEOV increases HES1 expression and promotes pancreatic cancer progression by enhancing SOX9 transactivity |
Q89848838 | Mitochondrial Protein UQCRC1 is Oncogenic and a Potential Therapeutic Target for Pancreatic Cancer |
Q99634411 | Roles for MDC1 in cancer development and treatment |
Q60909293 | SOX9 is a dose-dependent metastatic fate determinant in melanoma |
Q91838151 | The impact of TP53BP1 and MLH1 on metastatic capability in cases of locally advanced prostate cancer and their usefulness in clinical practice |
Q64063248 | miR-1-3p suppresses proliferation of hepatocellular carcinoma through targeting SOX9 |
Search more.